Detecting Heart Disease Using First Pass Imaging With Gated SPECT Perfusion
The aim of this study is to determine if stress first pass imaging in conjunction with a nuclear scan will improve the sensitivity for detecting heart disease. This study will also test the usefulness of a nuclear medicine camera, CDLCAM One Pass Angiography system.
Ischemic Heart Disease
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Detecting Heart Disease Using First Pass Imaging With Gated SPECT Perfusion|
- To determine if stress first pass imaging in conjunction with gated SPECT, with or with out low level exercise,will improve the sensitivity for detecting ischemic heart disease [ Time Frame: First pass imaging done in conjunction with SPECT study ] [ Designated as safety issue: No ]First pass imaging will be done in conjunction with the clinically indicated SPECT study.
- To determine if first pass imaging provides a more reproducible approach for evaluation of both rest and stress global LV function over gated SPECT perfusion imaging compared with 3D echocardiography [ Time Frame: Immediately following administration of regadenoson. ] [ Designated as safety issue: No ]Echocardiography will be done immediately following the administration of regadenoson.
|Study Start Date:||August 2010|
|Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|
Suspected or Diagnosed with Coronary artery disease
All patients with suspected or previously diagnosed coronary artery disease
Show Detailed Description
Please refer to this study by its ClinicalTrials.gov identifier: NCT01137409
|United States, Connecticut|
|Yale New Haven Hospital|
|New Haven, Connecticut, United States, 06510|
|Principal Investigator:||Albert Sinusas, MD||Yale University|